1. Home
  2. ACLS vs SYRE Comparison

ACLS vs SYRE Comparison

Compare ACLS & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axcelis Technologies Inc.

ACLS

Axcelis Technologies Inc.

HOLD

Current Price

$90.14

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$45.74

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACLS
SYRE
Founded
1995
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.6B
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
ACLS
SYRE
Price
$90.14
$45.74
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$101.50
$60.13
AVG Volume (30 Days)
676.2K
703.5K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.80
N/A
Revenue
$839,048,000.00
N/A
Revenue This Year
$1.93
N/A
Revenue Next Year
$7.91
N/A
P/E Ratio
$25.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$40.40
$10.91
52 Week High
$102.93
$49.31

Technical Indicators

Market Signals
Indicator
ACLS
SYRE
Relative Strength Index (RSI) 51.92 61.34
Support Level $78.24 $15.01
Resistance Level $93.22 N/A
Average True Range (ATR) 4.55 2.38
MACD 1.13 0.23
Stochastic Oscillator 42.38 64.14

Price Performance

Historical Comparison
ACLS
SYRE

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: